US Stock MarketDetailed Quotes

DAWN Day One Biopharmaceuticals

Watchlist
  • 9.995
  • +0.125+1.27%
Trading Feb 27 11:06 ET
1.01BMarket Cap-9.80P/E (TTM)

Day One Biopharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
46.81%-78.11M
27.47%-30.01M
236.93%50.75M
-15.78%-49.13M
-91.38%-49.73M
-33.66%-146.85M
-17.17%-41.37M
-59.66%-37.06M
-42.45%-42.43M
-20.51%-25.99M
Net income from continuing operations
49.45%-95.5M
-20.55%-65.71M
180.25%37.04M
90.39%-4.41M
-47.22%-62.41M
-32.87%-188.92M
-35.91%-54.51M
-22.11%-46.15M
-25.55%-45.86M
-52.78%-42.39M
Operating gains losses
---108M
--0
--0
----
----
----
----
----
----
----
Depreciation and amortization
429.77%2.03M
636.89%759K
653.54%746K
343.48%408K
30.34%116K
-27.87%383K
-42.78%103K
-40.00%99K
-30.83%92K
67.92%89K
Other non cash items
1,733.33%55M
--0
----
----
----
--3M
--0
----
----
----
Change In working capital
181.16%26.48M
603.37%26.74M
-5,254.56%-52.21M
5,872.13%50.74M
-83.74%1.22M
43.48%9.42M
412.84%3.8M
-114.19%-975K
-189.79%-879K
10,622.54%7.47M
-Change in receivables
---13.88M
---5.18M
--441K
----
----
--0
--0
--0
----
----
-Change in inventory
---3.24M
---560K
---2.55M
----
----
--0
--0
--0
----
----
-Change in prepaid assets
-45.52%-4.46M
-93.42%-2.23M
191.15%752K
-56.80%-3.87M
-35.85%884K
-262.53%-3.07M
-311.15%-1.16M
-154.93%-825K
25.78%-2.47M
223.47%1.38M
-Change in payables and accrued expense
231.94%42.79M
565.37%33.68M
-120,139.13%-55.31M
3,696.85%63.98M
-92.91%439K
66.17%12.89M
416.57%5.06M
-100.85%-46K
-61.42%1.69M
1,481.47%6.19M
-Change in other current liabilities
220.49%488K
821.70%765K
43.27%-59K
-11.11%-110K
-12.50%-108K
-16.71%-405K
34.97%-106K
-52.94%-104K
-47.76%-99K
-95.92%-96K
-Change in other working capital
--4.79M
--264K
----
----
----
----
----
----
----
----
Cash from discontinued investing activities
Operating cash flow
46.81%-78.11M
27.47%-30.01M
236.93%50.75M
-15.78%-49.13M
-91.38%-49.73M
-33.66%-146.85M
-17.17%-41.37M
-59.66%-37.06M
-42.45%-42.43M
-20.51%-25.99M
Investing cash flow
Cash flow from continuing investing activities
-279.93%-230.99M
-987.56%-269.64M
-176.14%-67.7M
-15.87%17.06M
897.71%89.29M
150.33%128.38M
1,474.66%30.38M
136.02%88.92M
438.07%20.27M
-74,520.00%-11.19M
Net PPE purchase and sale
-868.30%-2.17M
-17,637.50%-1.42M
-1,665.85%-724K
82.55%-26K
--0
-761.54%-224K
---8K
-925.00%-41K
-2,028.57%-149K
-73.33%-26K
Net intangibles purchase and sale
1,296.67%35.9M
--0
-1,733.33%-55M
----
----
---3M
--0
---3M
----
----
Net investment purchase and sale
-301.16%-264.73M
-982.65%-268.22M
-113.02%-11.98M
-461.44%-73.82M
899.57%89.29M
151.60%131.6M
1,475.02%30.39M
137.25%91.96M
440.95%20.42M
---11.17M
Cash from discontinued investing activities
Investing cash flow
-279.93%-230.99M
-987.56%-269.64M
-176.14%-67.7M
-15.87%17.06M
897.71%89.29M
150.33%128.38M
1,474.66%30.38M
136.02%88.92M
438.07%20.27M
-74,520.00%-11.19M
Financing cash flow
Cash flow from continuing financing activities
23.96%203.29M
210.05%1.85M
173,895.65%200.1M
-99.20%1.3M
-95.95%48K
-1.15%164M
-68.87%597K
-94.40%115K
0.11%162.1M
1.18M
Net common stock issuance
10.39%178.18M
--0
--178.18M
----
----
-0.12%161.41M
--0
--0
----
----
Proceeds from stock option exercised by employees
870.40%25.11M
210.05%1.85M
18,959.13%21.92M
87.43%1.3M
-95.95%48K
-39.69%2.59M
-68.87%597K
-94.40%115K
116.25%692K
--1.18M
Cash from discontinued financing activities
Financing cash flow
23.96%203.29M
210.05%1.85M
173,895.65%200.1M
-99.20%1.3M
-95.95%48K
-1.15%164M
-68.87%597K
-94.40%115K
0.11%162.1M
--1.18M
Net cash flow
Beginning cash position
170.68%230.78M
75.29%422.77M
26.64%239.62M
448.82%270.39M
170.68%230.78M
-70.01%85.26M
99.55%241.18M
-51.34%189.21M
-81.25%49.27M
-70.01%85.26M
Current changes in cash
-172.71%-105.82M
-2,764.81%-297.8M
252.43%183.15M
-121.99%-30.78M
210.04%39.61M
173.11%145.52M
70.80%-10.4M
119.39%51.97M
10.94%139.94M
-66.81%-35.99M
End cash Position
-45.85%124.97M
-45.85%124.97M
75.29%422.77M
26.64%239.62M
448.82%270.39M
170.68%230.78M
170.68%230.78M
99.55%241.18M
-51.34%189.21M
-81.25%49.27M
Free cash flow
-1.54%-152.38M
24.05%-31.43M
87.61%-4.97M
-55.60%-66.26M
-91.18%-49.73M
-36.56%-150.08M
-17.19%-41.38M
-72.73%-40.11M
-42.92%-42.58M
-20.54%-26.01M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 46.81%-78.11M27.47%-30.01M236.93%50.75M-15.78%-49.13M-91.38%-49.73M-33.66%-146.85M-17.17%-41.37M-59.66%-37.06M-42.45%-42.43M-20.51%-25.99M
Net income from continuing operations 49.45%-95.5M-20.55%-65.71M180.25%37.04M90.39%-4.41M-47.22%-62.41M-32.87%-188.92M-35.91%-54.51M-22.11%-46.15M-25.55%-45.86M-52.78%-42.39M
Operating gains losses ---108M--0--0----------------------------
Depreciation and amortization 429.77%2.03M636.89%759K653.54%746K343.48%408K30.34%116K-27.87%383K-42.78%103K-40.00%99K-30.83%92K67.92%89K
Other non cash items 1,733.33%55M--0--------------3M--0------------
Change In working capital 181.16%26.48M603.37%26.74M-5,254.56%-52.21M5,872.13%50.74M-83.74%1.22M43.48%9.42M412.84%3.8M-114.19%-975K-189.79%-879K10,622.54%7.47M
-Change in receivables ---13.88M---5.18M--441K----------0--0--0--------
-Change in inventory ---3.24M---560K---2.55M----------0--0--0--------
-Change in prepaid assets -45.52%-4.46M-93.42%-2.23M191.15%752K-56.80%-3.87M-35.85%884K-262.53%-3.07M-311.15%-1.16M-154.93%-825K25.78%-2.47M223.47%1.38M
-Change in payables and accrued expense 231.94%42.79M565.37%33.68M-120,139.13%-55.31M3,696.85%63.98M-92.91%439K66.17%12.89M416.57%5.06M-100.85%-46K-61.42%1.69M1,481.47%6.19M
-Change in other current liabilities 220.49%488K821.70%765K43.27%-59K-11.11%-110K-12.50%-108K-16.71%-405K34.97%-106K-52.94%-104K-47.76%-99K-95.92%-96K
-Change in other working capital --4.79M--264K--------------------------------
Cash from discontinued investing activities
Operating cash flow 46.81%-78.11M27.47%-30.01M236.93%50.75M-15.78%-49.13M-91.38%-49.73M-33.66%-146.85M-17.17%-41.37M-59.66%-37.06M-42.45%-42.43M-20.51%-25.99M
Investing cash flow
Cash flow from continuing investing activities -279.93%-230.99M-987.56%-269.64M-176.14%-67.7M-15.87%17.06M897.71%89.29M150.33%128.38M1,474.66%30.38M136.02%88.92M438.07%20.27M-74,520.00%-11.19M
Net PPE purchase and sale -868.30%-2.17M-17,637.50%-1.42M-1,665.85%-724K82.55%-26K--0-761.54%-224K---8K-925.00%-41K-2,028.57%-149K-73.33%-26K
Net intangibles purchase and sale 1,296.67%35.9M--0-1,733.33%-55M-----------3M--0---3M--------
Net investment purchase and sale -301.16%-264.73M-982.65%-268.22M-113.02%-11.98M-461.44%-73.82M899.57%89.29M151.60%131.6M1,475.02%30.39M137.25%91.96M440.95%20.42M---11.17M
Cash from discontinued investing activities
Investing cash flow -279.93%-230.99M-987.56%-269.64M-176.14%-67.7M-15.87%17.06M897.71%89.29M150.33%128.38M1,474.66%30.38M136.02%88.92M438.07%20.27M-74,520.00%-11.19M
Financing cash flow
Cash flow from continuing financing activities 23.96%203.29M210.05%1.85M173,895.65%200.1M-99.20%1.3M-95.95%48K-1.15%164M-68.87%597K-94.40%115K0.11%162.1M1.18M
Net common stock issuance 10.39%178.18M--0--178.18M---------0.12%161.41M--0--0--------
Proceeds from stock option exercised by employees 870.40%25.11M210.05%1.85M18,959.13%21.92M87.43%1.3M-95.95%48K-39.69%2.59M-68.87%597K-94.40%115K116.25%692K--1.18M
Cash from discontinued financing activities
Financing cash flow 23.96%203.29M210.05%1.85M173,895.65%200.1M-99.20%1.3M-95.95%48K-1.15%164M-68.87%597K-94.40%115K0.11%162.1M--1.18M
Net cash flow
Beginning cash position 170.68%230.78M75.29%422.77M26.64%239.62M448.82%270.39M170.68%230.78M-70.01%85.26M99.55%241.18M-51.34%189.21M-81.25%49.27M-70.01%85.26M
Current changes in cash -172.71%-105.82M-2,764.81%-297.8M252.43%183.15M-121.99%-30.78M210.04%39.61M173.11%145.52M70.80%-10.4M119.39%51.97M10.94%139.94M-66.81%-35.99M
End cash Position -45.85%124.97M-45.85%124.97M75.29%422.77M26.64%239.62M448.82%270.39M170.68%230.78M170.68%230.78M99.55%241.18M-51.34%189.21M-81.25%49.27M
Free cash flow -1.54%-152.38M24.05%-31.43M87.61%-4.97M-55.60%-66.26M-91.18%-49.73M-36.56%-150.08M-17.19%-41.38M-72.73%-40.11M-42.92%-42.58M-20.54%-26.01M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------

Trending Stocks

Top Gaining Chinese Stocks Top Gaining Chinese Stocks
No. Symbol % Chg
WANDA BEARING
920002
+30.00%
HENDERA
831152
+29.97%
LINGOOD
833284
+29.95%
4
WUHAN LAND
830779
+25.43%
5
TECHVISION
832876
+21.28%
Log In for the Full List
Unlock Now
Investment Course
Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.
Monetary Policy: Navigating the Fed's Rate Cut Cycle
Changing Fed policy is altering the market math for investors.
Discussing
Big Tech’s earnings season in full swing! Nvidia is the only one left
On Thursday, $Amazon (AMZN.US)$ stock fell after the firm reported Q4 adjusted earnings of $1.86/share, vs estimates of $1.50/share, on reve Show More
AMZN earnings preview: Grab rewards by guessing the opening price!